PL药业公司发展战略研究

发布时间：2018-11-26 20:38

【摘要】：随着中国社会主义市场经济的不断发展,人们越来越关注健康和个人的健康生活,药物的安全性显得尤为重要,关系到人民的身体健康安全、社会和经济生活。而随着日常保健的需要和回归自然的号召,为中国传统医药产业的发展提供了广阔的空间,而中国医药行业未来的生存和发展,成为大家关注的焦点。 PL药业公司成立于1998年,公司的主营业务：研究生产中药配方颗粒,中成药和灵芝,乌发浓等其他保健食品。目前共开发了150多个复方和600多个单方品种。主要使用于国内各省市的中医医院和综合性医院以及香港澳门医院,其中,国内已有超过300家医院在使用我公司的产品。公司的产品出口到香港、澳门、新加坡、美国等国家和地区。本论文中,以发展战略理论为基础,结合中国的医药行业外部环境的现状,得出外部因素分析矩阵,以帮助企业分析,总结和评估政治、经济、市场及竞争对手等信息。找出对企业影响最重要的因素。然后从PL药业公司内部环境：生产运作管理、信息化建设情况、技术与科研状况、业务模式、人力资源和营销模式分析和研究,做出内部因素评价矩阵,分析企业在该行业中的地位。根据之前的分析结果,再对企业进行了SWOT分析,得出适合企业的备选战略,运用QSPM分析法找出企业发展的总体战略,即后向一体化增长型战略、竞争战略—成本领先战略。最后,在运营管理、价值链、人力资源、知识产权贸易、企业信息化、产品优化、国际贸易等方面提出了具体的发展战略实施途径和方法,并且对类似的中药制药企业发展战略管理具有一定的参考意义。
[Abstract]:With the continuous development of China's socialist market economy, people pay more and more attention to health and personal healthy life. The safety of drugs is particularly important, which is related to the health and safety of the people, social and economic life. With the need of daily health care and the call to return to nature, the development of Chinese traditional medicine industry has provided a broad space, and the future survival and development of Chinese medicine industry has become the focus of attention. PL Pharmaceutical Co., Ltd. was founded in 1998, the company's main business: research and production of traditional Chinese medicine formula granules, proprietary Chinese medicine and Ganoderma lucidum, Wufa thick and other health food. At present, a total of more than 150 compound and more than 600 unilateral varieties. It is mainly used in Chinese medicine hospitals and general hospitals in various provinces and cities in China and hospitals in Hong Kong and Macao. Among them, more than 300 hospitals in China are using our products. The company's products are exported to Hong Kong, Macao, Singapore, the United States and other countries and regions. In this paper, based on the development strategy theory and the current situation of the external environment of Chinese pharmaceutical industry, the external factor analysis matrix is obtained to help enterprises analyze, summarize and evaluate the information of politics, economy, market and competitors. Identify the most important factors affecting the business. Then from the PL pharmaceutical company internal environment: production and operation management, information construction, technology and scientific research status, business model, human resources and marketing model analysis and research, to make internal factor evaluation matrix, Analyze the position of the enterprise in the industry. According to the previous analysis results, the SWOT analysis of the enterprise is carried out, and the alternative strategy suitable for the enterprise is obtained, and the overall strategy of the enterprise development is found by using the QSPM analysis method, that is, the backward integrated growth strategy, the competitive strategy and the cost leading strategy. Finally, in the aspects of operation management, value chain, human resources, intellectual property trade, enterprise informatization, product optimization, international trade and so on, the paper puts forward the specific ways and methods to implement the development strategy. And it has certain reference significance to the development strategy management of the similar traditional Chinese medicine pharmaceutical enterprises.
【学位授予单位】：广西大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F272;F426.72

【参考文献】